Alpa Laboratories Limited
Symboli: ALPA.BO
BSE
90.5
INRMarkkinahinta tänään
10.3959
P/E-suhde
-0.9674
PEG-suhde
1.90B
MRK Cap
- 0.00%
DIV Tuotto
Alpa Laboratories Limited (ALPA-BO) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 808.4 | 702.7 | 424.9 | |||||||||||||||
balance-sheet.row.short-term-investments | 0 | 720.3 | 687 | 406.9 | |||||||||||||||
balance-sheet.row.net-receivables | 0 | 501.4 | 430.8 | 381.4 | |||||||||||||||
balance-sheet.row.inventory | 0 | 126.4 | 154.6 | 165.6 | |||||||||||||||
balance-sheet.row.other-current-assets | 0 | 81.6 | 72.7 | 107.8 | |||||||||||||||
balance-sheet.row.total-current-assets | 0 | 1491.2 | 1380.1 | 1210.9 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 69.6 | 92.2 | 87.3 | |||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0.8 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0.8 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.long-term-investments | 0 | 96.5 | 61.5 | 104.9 | |||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 9.3 | 0 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 14.5 | 8.3 | 0 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 181.4 | 172.3 | 192.8 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 0 | 1672.7 | 1552.4 | 1403.7 | |||||||||||||||
balance-sheet.row.account-payables | 0 | 150.6 | 149.2 | 247.3 | |||||||||||||||
balance-sheet.row.short-term-debt | 0 | 15.3 | 37.2 | 1.8 | |||||||||||||||
balance-sheet.row.tax-payables | 0 | 22.8 | 25.7 | 2.9 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 7.8 | 21.2 | 0.1 | |||||||||||||||
Deferred Revenue Non Current | 0 | 0 | -25.7 | -2.2 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 0 | 73.4 | 67.4 | 38.8 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 7.8 | 21.2 | 0.1 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-liab | 0 | 326.9 | 335.1 | 327.3 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 0 | 210.4 | 210.4 | 210.4 | |||||||||||||||
balance-sheet.row.retained-earnings | 0 | 585.8 | 457.3 | 316.4 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 760 | 760 | 760 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -210.4 | -210.4 | -210.4 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1345.8 | 1217.3 | 1076.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1672.7 | 1552.4 | 1403.7 | |||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-equity | 0 | 1345.8 | 1217.3 | 1076.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||
Total Investments | 0 | 77.7 | 74.7 | 101.5 | |||||||||||||||
balance-sheet.row.total-debt | 0 | 23 | 58.5 | 1.9 | |||||||||||||||
balance-sheet.row.net-debt | 0 | -65.1 | 42.7 | -16.1 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 156.8 | 195.6 | 107.9 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 13.3 | 16.6 | 12.3 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -8 | 14.5 | -103.4 | |||||||||||||||
cash-flows.row.account-receivables | 0 | -66.4 | -0.3 | -185 | |||||||||||||||
cash-flows.row.inventory | 0 | 28.2 | 11 | -40.1 | |||||||||||||||
cash-flows.row.account-payables | 0 | 19.8 | -78.9 | 127.2 | |||||||||||||||
cash-flows.row.other-working-capital | 0 | 10.3 | 82.8 | -5.5 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -73 | -127.3 | -33.8 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -11.3 | -21.9 | -32.2 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | -5 | 42.3 | 3.7 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -0.3 | -191.8 | 7.9 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 12.3 | 15.4 | 79.1 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | 25.5 | -0.1 | 0.1 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 21.3 | -156.1 | 58.6 | |||||||||||||||
cash-flows.row.debt-repayment | 0 | -35.4 | -21.2 | -1.8 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-financing-activites | 0 | -2.5 | 75.6 | 3.7 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -37.9 | 54.4 | 1.9 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | -0.1 | |||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 72.4 | -2.3 | 43.4 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 88.1 | 15.8 | 105.1 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 15.8 | 18 | 61.7 | |||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 89 | 99.4 | -17 | |||||||||||||||
cash-flows.row.capital-expenditure | 0 | -11.3 | -21.9 | -32.2 | |||||||||||||||
cash-flows.row.free-cash-flow | 0 | 77.8 | 77.5 | -49.2 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 924.1 | 1105.1 | 964.1 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 615 | 760.9 | 647.6 | |||||||||||||||
income-statement-row.row.gross-profit | 0 | 309.1 | 344.3 | 316.6 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 0 | 28.8 | 1.5 | 0.5 | |||||||||||||||
income-statement-row.row.operating-expenses | 0 | 235.5 | 248.8 | 219.4 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 850.5 | 1009.7 | 867 | |||||||||||||||
income-statement-row.row.interest-income | 0 | 10.4 | 14.6 | 6.5 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.8 | 1.1 | 0.3 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 81 | 101.1 | 41.7 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 28.8 | 1.5 | 0.5 | |||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 81 | 101.1 | 41.7 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.8 | 1.1 | 0.3 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 13.3 | 16.6 | 12.3 | |||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 0 | 67.5 | 79.6 | 69 | |||||||||||||||
income-statement-row.row.income-before-tax | 0 | 158.9 | 195.6 | 107.9 | |||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 33.1 | 54.7 | 35.4 | |||||||||||||||
income-statement-row.row.net-income | 0 | 125.8 | 140.9 | 72.5 |
Usein kysytty kysymys
Mikä on Alpa Laboratories Limited (ALPA.BO) taseen loppusumma?
Alpa Laboratories Limited (ALPA.BO) kokonaisvarat ovat 1672699000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.350.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 7.032.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.157.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.135.
Mikä on Alpa Laboratories Limited (ALPA.BO) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 125828000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 23040000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 235520000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.